| 2D Structure | |
| CID | 5161 |
| IUPAC Name | 2-(2-hydroxybenzoyl)oxybenzoic acid |
| InChI | InChI=1S/C14H10O5/c15-11-7-3-1-5-9(11)14(18)19-12-8-4-2-6-10(12)13(16)17/h1-8,15H,(H,16,17) |
| InChI Key | WVYADZUPLLSGPU-UHFFFAOYSA-N |
| Canonical SMILES | None |
| Isomeric SMILES | None |
| Molecular Formula | C14H10O5 |
| Molecular Weight | 258.23 |
| synonyms | ['Salsalate', '552-94-3', 'sasapyrine', 'Salicylsalicylic acid', 'Disalcid', '2-Carboxyphenyl salicylate', 'Disalicylic acid', 'Sasapyrinum', 'Sasapyrin', '2-(2-hydroxybenzoyl)oxybenzoic acid', 'Disalicylsaeure', 'Salsalato', '2-((2-Hydroxybenzoyl)oxy)benzoic acid', 'Benzoic acid, 2-hydroxy-, 2-carboxyphenyl ester', 'Salicylic acid, bimolecular ester', 'Salsalatum', 'NSC-49171', 'O-Salicylcylsalicylsaeure', 'Salflex', 'Salicyloxysalicylic acid', 'Disalicyclic acid', 'Mono-gesic', '2-[(2-Hydroxybenzoyl)oxy]benzoic acid', 'CHEBI:9014', 'V9MO595C9I', 'Salicylic acid bimolecular ester', 'DTXSID1023572', 'NSC49171', 'DTXCID203572', '4-10-00-00165 (Beilstein Handbook Reference)', '2-((2-hydroxyphenyl)carbonyloxy)benzoic acid', '2-[(2-hydroxyphenyl)carbonyloxy]benzoic acid', 'Salsitab', 'Salsalate Rx', 'RefChem:58291', 'N02BA06', '209-027-4', 'Diplosal', 'Salicyloylsalicylic acid', 'Saloxium', 'Salysal', 'Diacesal', 'Sasapirin', 'Disalyl', 'Nobacid', 'Salical', 'Salina', 'o-Salicylsalicylic acid', 'Sal Ester Sal', 'Salicylic acid, salicylate', 'Salsalatum [INN-Latin]', 'MFCD00020252', '2-Hydroxybenzoic acid 2-carboxyphenyl ester', 'Aspirin Impurity E', 'Sasapyrine (JAN)', 'Salsalate (Standard)', 'Salicylsalicylic acid;Disalicylic acid', 'NCGC00096014-01', 'SASAPYRINE [JAN]', 'Salicylic Acid Salicylate', 'Salsalato [INN-Spanish]', '2-[(2-Hydroxybenzoyl)oxy]benzoic Acid (Salicylsalicylic Acid)', 'O-Salicyloylsalicylic Acid', 'Disalcid (TN)', 'CAS-552-94-3', '2-(2-hydroxyphenylcarbonyloxy)benzoic acid', 'Salsalate (USP/INN)', 'EINECS 209-027-4', 'NSC 49171', '2-Salicyloyloxybenzoic Acid', 'BRN 2590908', 'UNII-V9MO595C9I', 'Disalgesic', 'Sasapyrine?', 'Salsalate [USAN:USP:INN:BAN]', 'Salicylic Acid 2-Carboxyphenyl Ester', 'carboxyphenyl salicylate', 'Spectrum_001998', 'SALSALATE [INN]', 'SALSALATE [MI]', 'Aspirin EP Impurity E', 'SALSALATE [USAN]', 'Spectrum2_000693', 'Spectrum3_000173', 'Spectrum4_000940', 'Spectrum5_000670', 'SALSALATE [VANDF]', 'Epitope ID:613456', 'SALSALATE [MART.]', 'SALSALATE [USP-RS]', 'SALSALATE [WHO-DD]', '2-{[(2-hydroxyphenyl)carbonyl]oxy}benzoic acid', 'SCHEMBL15562', 'BSPBio_001665', 'KBioGR_001500', 'KBioSS_002572', 'SPECTRUM200331', 'Salsalate - Bio-X trade mark', 'SPBio_000845', 'CHEMBL154111', 'orb1310554', 'SALSALATE [USP IMPURITY]', 'Salsalate, >=98% (HPLC)', 'SCHEMBL18096513', 'SCHEMBL29362887', 'BDBM85244', 'HY-B1245R', 'KBio2_002563', 'KBio2_005131', 'KBio2_007699', 'KBio3_001165', 'MSK8004', 'SALSALATE [USP MONOGRAPH]', 'GLXC-08143', 'HMS2091A05', 'HMS3652P07', 'HMS3885J09', 'HMS5082F08', 'HMS6018B18', 'Pharmakon1600-00200331', 'HY-B1245', 'NSC_5161', 'Benzoic acid, 2-carboxyphenyl ester', 'Tox21_111548', 'CCG-39652', 'EBC-26349', 'MSK8004-100A', 'NSC755823', 's4188', 'SBB003097', 'AKOS003368478', 'Tox21_111548_1', 'CS-4891', 'DB01399', 'FS27786', 'NSC-755823', 'NCGC00096014-02', 'NCGC00096014-03', 'AC-18298', 'AS-12645', 'BS300124', 'CAS_552-94-3', 'ST083489', '2-[(2-Hydroxybenzoyl)oxy]benzoic acid #', 'SBI-0206687.P002', 'DB-020760', 'CS-0694787', 'NS00009927', 'SW219189-1', 'C75590', 'D00428', 'Sasapyrine Solution in Acetonitrile, 100ug/mL', 'AB01563259_01', 'AB01563259_02', 'F241207', 'SR-05000001536', 'CARBASALATE CALCIUM IMPURITY D [EP IMPURITY]', 'Q1320691', 'SR-05000001536-1', 'ACETYLSALICYLIC ACID IMPURITY E [EP IMPURITY]', 'BRD-K48892307-001-04-1', 'BRD-K48892307-001-05-8', 'Aspirin Impurity E; Acetylsalicylic Acid EP Impurity E', 'DL-LYSINE ACETYLSALICYLATE IMPURITY M [EP IMPURITY]', 'Salsalate, United States Pharmacopeia (USP) Reference Standard', 'Salsalate (Aspirin Impurity E), Pharmaceutical Secondary Standard; Certified Reference Material'] |
From Pubchem